Level-2 ATC description | Target genes | HIV-1 interacting | Corrected p |
---|---|---|---|
Immunosuppressive agents | 36 (3%) | 29 (12%) | 1.87 × 10-13 |
Antineoplastic agents | 100 (8%) | 47 (20%) | 7.87 × 10-9 |
Anti-inflammitory and antirheumatic products | 27 (2%) | 18 (8%) | 3.03 × 10-6 |
Stomatological preparations | 30 (3%) | 19 (8%) | 3.35 × 10-6 |
Lipid modifying agents | 46 (4%) | 23 (10%) | 4.62 × 10-5 |
Antithrombotic agents | 65 (5%) | 29 (12%) | 4.08 × 10-5 |